The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) in eligible adults and children aged two years and above.
In a landmark regulatory achievement that reflects the UAE's leadership in accelerating access to innovative therapies, the Emirates Drug Establishment has announced the approval of "Tolebrutinib" as the world's first oral treatment for non-relapsing secondary progressive multiple sclerosis
Abdulrahman bin Mohamed Al Owais, Minister of Health and Prevention (MoHAP), inaugurated the third edition of World Local Production Forum (WLPF) in Abu Dhabi, in the presence of Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Board of the Emirates Dru
The Board of Directors of the Emirates Drug Establishment (EDE) held its fourth meeting since its establishment at the end of last year, to review and develop the main initiatives to be taken for the regulation and management of the UAE's healthcare and pharmaceutical sectors - all of which
Following its formation by the UAE Cabinet in November 2023 and holding of its inaugural meeting last month, the Board of Directors of the Emirates Drug Establishment (EDE) discussed in its second meeting the first 100-day plan for the formation of the new federal body tasked with overseeing